MedDataX Logo

Safety and Efficacy of Daily Use of Micamlo® Combination Tablets AP in Patients With Hypertension

NCT ID: NCT01353274

Last Updated: 2014-08-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1157 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-05-31

Study Completion Date

2013-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Investigation of safety and efficacy of daily use of Micamlo Combination Tablets AP in patients with Hypertension

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

To Evaluate Real-world Safety, Effectiveness and Appropriate Use of Micatrio® Combination Tablets Treatment in Patients With Hypertension

NCT03021265

Hypertension
COMPLETED

Post-Marketing Surveillance of Micombi Tablets Survey on the Long-term Use

NCT01050062

Hypertension
COMPLETED

An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

NCT00618774

Hypertension
COMPLETED PHASE3

Add-on to Micamlo BP Trial

NCT01975246

Hypertension
COMPLETED PHASE3

Hypertension Control Based on Home Blood Pressure

NCT00198562

Hypertension
UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with hypertension

Micamlo

Intervention Type DRUG

Telmisartan plus Amlodipine T40/A5

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Micamlo

Telmisartan plus Amlodipine T40/A5

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Male and Female patients with hypertension who did not receive of MICAMLO Combination Tablets AP before the start of the study

Exclusion Criteria

* Patients with a history of hypersensitivity to any ingredient of Micamlo Combination Tablets AP and dihydropyridine derivatives
* Pregnant woman or possibly pregnant woman
* Patients with extremely poor bile secretion or patients with serious hepatic disorder
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 106

Nagaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 235

Nagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 254

Nago, , Japan

Site Status

Boehringer Ingelheim Investigational Site 139

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 140

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 141

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 142

Nagoya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 199

Akaiwa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 83

Akishima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 25

Akita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 188

Amagasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 116

Anamizu-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 212

Anan, , Japan

Site Status

Boehringer Ingelheim Investigational Site 145

Anjo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 11

Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 12

Aomori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 192

Arita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 7

Asahikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 104

Atsugi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 57

Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 58

Chiba, , Japan

Site Status

Boehringer Ingelheim Investigational Site 232

Chikuzen-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 143

Chita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 23

Daisen, , Japan

Site Status

Boehringer Ingelheim Investigational Site 24

Daisen, , Japan

Site Status

Boehringer Ingelheim Investigational Site 10

Date, , Japan

Site Status

Boehringer Ingelheim Investigational Site 90

Fuchū, , Japan

Site Status

Boehringer Ingelheim Investigational Site 52

Fujimino, , Japan

Site Status

Boehringer Ingelheim Investigational Site 129

Fujinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 103

Fujisawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 158

Fukuchiyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 224

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 225

Fukuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 29

Fukushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 13

Hachinohe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 130

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 131

Hamamatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 219

Handa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 171

Hannan, , Japan

Site Status

Boehringer Ingelheim Investigational Site 204

Hatsukaichi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 208

Higashihiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 5

Higashikagura-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 66

Higashimurayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 151

Hikone, , Japan

Site Status

Boehringer Ingelheim Investigational Site 179

Himeji, , Japan

Site Status

Boehringer Ingelheim Investigational Site 180

Himeji, , Japan

Site Status

Boehringer Ingelheim Investigational Site 181

Himeji, , Japan

Site Status

Boehringer Ingelheim Investigational Site 169

Hirakata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 170

Hirakata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 201

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 202

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 203

Hiroshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 38

Hitachi-Naka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 37

Hitachiota, , Japan

Site Status

Boehringer Ingelheim Investigational Site 62

Ichikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 17

Ichinoseki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 223

Iizuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 175

Ikeda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 238

Iki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 63

IKisarazu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 191

Ikoma, , Japan

Site Status

Boehringer Ingelheim Investigational Site 111

Imizu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 189

Itami, , Japan

Site Status

Boehringer Ingelheim Investigational Site 253

Itoman, , Japan

Site Status

Boehringer Ingelheim Investigational Site 233

Itoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 252

Izumi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 249

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 250

Kagoshima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 125

Kakamigahara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 229

Kama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 152

Kameoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 241

Kamiamakusa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 242

Kamiamakusa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 22

Kamimachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 113

Kanazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 114

Kanazawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 237

Kanzaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 144

Kariya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 33

Kasama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 34

Kasama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 137

Kasugai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 138

Kasugai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 48

Kasukabe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 49

Kasukabe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 177

Katō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 178

Katō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 117

Katsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 121

Kawachi-Nagano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 51

Kawaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 100

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 101

Kawasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 43

Kiryū, , Japan

Site Status

Boehringer Ingelheim Investigational Site 176

Kita-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 15

Kitakami, , Japan

Site Status

Boehringer Ingelheim Investigational Site 226

Kitakyushu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 227

Kitakyushu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 4

Kitami, , Japan

Site Status

Boehringer Ingelheim Investigational Site 183

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 184

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 185

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 186

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 187

Kobe, , Japan

Site Status

Boehringer Ingelheim Investigational Site 220

Kochi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 56

Koshigaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 193

Kotoura-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 240

Kotouracho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 30

Kōriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 53

Kumagaya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 243

Kumamoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 196

Kurashiki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 205

Kure, , Japan

Site Status

Boehringer Ingelheim Investigational Site 206

Kure, , Japan

Site Status

Boehringer Ingelheim Investigational Site 230

Kurume, , Japan

Site Status

Boehringer Ingelheim Investigational Site 231

Kurume, , Japan

Site Status

Boehringer Ingelheim Investigational Site 149

Kusatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 9

Kushiro, , Japan

Site Status

Boehringer Ingelheim Investigational Site 153

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 154

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 155

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 156

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 157

Kyoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 99

Matsuda-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 64

Matsudo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 65

Matsudo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 195

Matsue, , Japan

Site Status

Boehringer Ingelheim Investigational Site 119

Matsumoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 120

Matsumoto, , Japan

Site Status

Boehringer Ingelheim Investigational Site 234

Matsuura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 216

Matsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 217

Matsuyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 148

Matsuzaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 207

Mihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 122

Minamiminowa-mura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 248

Miyazaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 126

Mizunami, , Japan

Site Status

Boehringer Ingelheim Investigational Site 60

Mobara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 61

Mobara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 16

Morioka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 27

Murayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 105

Nagaoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 228

Nakagawamachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 39

Nakagawamachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 245

Nakatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 127

Nakatsugawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 59

Narita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 18

Natori, , Japan

Site Status

Boehringer Ingelheim Investigational Site 8

Nayoro, , Japan

Site Status

Boehringer Ingelheim Investigational Site 246

Nichinan, , Japan

Site Status

Boehringer Ingelheim Investigational Site 31

Nihonmatsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 107

Niigata, , Japan

Site Status

Boehringer Ingelheim Investigational Site 200

Niimi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 6

Nikki-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 128

Nishiizu-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 182

Nishinomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 112

Nomi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 134

Numazu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 197

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 198

Okayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 14

Omamachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 159

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 160

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 161

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 162

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 163

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 164

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 165

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 166

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 167

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 168

Osaka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 40

Oyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 26

Ōdate, , Japan

Site Status

Boehringer Ingelheim Investigational Site 124

Ōgaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 244

Ōita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 239

Ōmura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 35

Ryūgasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 236

Saga, , Japan

Site Status

Boehringer Ingelheim Investigational Site 102

Sagamihara, , Japan

Site Status

Boehringer Ingelheim Investigational Site 46

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 47

Saitama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 172

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 173

Sakai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 215

Sakaidechō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 118

Sakakimachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 108

Sanjyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 41

Sano, , Japan

Site Status

Boehringer Ingelheim Investigational Site 1

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 2

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 3

Sapporo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 55

Sayama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 21

Sendai, , Japan

Site Status

Boehringer Ingelheim Investigational Site 115

Shikamachichō-shimoutagaura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 210

Shimonoseki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 19

Shiogama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 32

Shirakawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 132

Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 133

Shizuoka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 50

Sōka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 174

Suita, , Japan

Site Status

Boehringer Ingelheim Investigational Site 147

Suzuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 69

Tachikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 70

Tachikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 71

Tachikawa, , Japan

Site Status

Boehringer Ingelheim Investigational Site 20

Tagajyo, , Japan

Site Status

Boehringer Ingelheim Investigational Site 44

Takasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 45

Takasaki, , Japan

Site Status

Boehringer Ingelheim Investigational Site 150

Takashima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 84

Tama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 28

Tendō, , Japan

Site Status

Boehringer Ingelheim Investigational Site 213

Tokushima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 72

Tokyo Adachi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 73

Tokyo Adachi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 74

Tokyo Bunkyo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 75

Tokyo Bunkyo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 79

Tokyo Chuo-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 77

Tokyo Edofawa-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 76

Tokyo Itabashi-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 89

Tokyo Katsushika-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 85

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 86

Tokyo Meguro-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 81

Tokyo Nerima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 82

Tokyo Nerima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 87

Tokyo Ota-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 67

Tokyo Shinjyuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 68

Tokyo Shinjyuku-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 78

Tokyo Sumida-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 88

Tokyo Sumida-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 80

Tokyo Toshima-ku, , Japan

Site Status

Boehringer Ingelheim Investigational Site 214

Tonosho-cho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 221

Tosashimizu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 110

Toyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 135

Toyohashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 136

Toyohashi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 109

Tōkamachi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 146

Tsu, , Japan

Site Status

Boehringer Ingelheim Investigational Site 36

Tsuchiura, , Japan

Site Status

Boehringer Ingelheim Investigational Site 247

Tsunocho, , Japan

Site Status

Boehringer Ingelheim Investigational Site 209

Ube, , Japan

Site Status

Boehringer Ingelheim Investigational Site 123

Ueda, , Japan

Site Status

Boehringer Ingelheim Investigational Site 42

Utsunomiya, , Japan

Site Status

Boehringer Ingelheim Investigational Site 218

Uwajima, , Japan

Site Status

Boehringer Ingelheim Investigational Site 251

Wadomari, , Japan

Site Status

Boehringer Ingelheim Investigational Site 211

Yamaguchi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 190

Yamatokooriyama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 222

Yame, , Japan

Site Status

Boehringer Ingelheim Investigational Site 93

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 94

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 95

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 96

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 97

Yokohama, , Japan

Site Status

Boehringer Ingelheim Investigational Site 91

Yokosuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 92

Yokosuka, , Japan

Site Status

Boehringer Ingelheim Investigational Site 54

Yokoze-machi, , Japan

Site Status

Boehringer Ingelheim Investigational Site 194

Yonago, , Japan

Site Status

Boehringer Ingelheim Investigational Site 98

Zama, , Japan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Japan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1235.38

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Open Label Study Telmisartan and Amlodipine in Hypertension
NCT00614380 COMPLETED PHASE3
Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
NCT00509470 COMPLETED PHASE4
Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension
NCT00425373 COMPLETED PHASE2/PHASE3
Filtered Trial for Telmisartan 40mg Non-responder
NCT00550953 COMPLETED PHASE3
MK-0954E Study in Participants With Hypertension (MK-0954E-357)
NCT01302691 COMPLETED PHASE3
Use of Ramipril and Felodipine Combination Therapy in Hypertension: An Effectiveness Study With Local Patients in Argentina
NCT00507845 COMPLETED PHASE4
Safety and Efficacy of Chlorthalidone + Amiloride to Elderly Patients Treatment With Arterial Hypertension
NCT01191450 COMPLETED PHASE3
Recurrent Stroke Prevention Clinical Outcome Study
NCT01198496 UNKNOWN PHASE4
Safety and Effects of Ramipril Combined With Candesartan
NCT00356395 COMPLETED PHASE4
Once-daily Fixed Combination of Three Antihypertensive Drugs
NCT02710539 UNKNOWN PHASE4
A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients
NCT00627952 COMPLETED PHASE3
Filtered Trial for Amlodipine Non-responder
NCT00558064 COMPLETED PHASE3
Study of Co-administration of Olmesartan Medoxomil Plus Amlodipine in Patients With Mild to Severe Hypertension
NCT00185133 COMPLETED PHASE3
Pharmacokinetics of Different Formulations of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) in Japanese Healthy Male Volunteers
NCT02183675 COMPLETED PHASE1
Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
NCT00443456 COMPLETED PHASE3
Irbesartan/Amlodipine in Hypertensive Patients Uncontrolled on Amlodipine 5 mg Monotherapy
NCT00956644 COMPLETED PHASE3
A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient
NCT00415623 COMPLETED PHASE3
A Study to Determine the Effectiveness and Tolerability of MK8141 in Patients With High Blood Pressure (MK-8141-006)
NCT00543413 COMPLETED PHASE2
A Real-world Study of the Safety of Hypertension Medication Therapy in Japanese Patients With Naïve Hypertension
NCT06683768 COMPLETED
An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
NCT00982735 COMPLETED
Irbesartan and Amlodipine Combination in Controlling Blood Pressure
NCT00950066 COMPLETED PHASE2
Amlodipine as add-on to Olmesartan in Hypertension
NCT00220220 COMPLETED PHASE3
3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension
NCT00153049 COMPLETED PHASE2
The Effects of Antihypertensive Agents on Central Blood Pressure in Healthy Participants and Participants With Hypertension (MK-0000-166) (COMPLETED)
NCT01130168 COMPLETED PHASE1
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension
NCT04936035 COMPLETED PHASE2